GEKID: Cancer in Germany 2007/2008, Version 8. 2012, Berlin, Germany: Robert-Koch-Institute and the Association of Population-based Cancer Registries in Germany (GEKID)
Google Scholar
Ruijter ET, van de Kaa CA, Schalken JA, Debruyne FM, Ruiter DJ: Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications. J Pathol. 1996, 180 (3): 295-299. 10.1002/(SICI)1096-9896(199611)180:3<295::AID-PATH663>3.0.CO;2-W.
Article
CAS
PubMed
Google Scholar
Macintosh CA, Stower M, Reid N, Maitland NJ: Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Res. 1998, 58 (1): 23-28.
CAS
PubMed
Google Scholar
Kollmeier MA, Zelefsky MJ: How to select the optimal therapy for early-stage prostate cancer. Crit Rev Oncol Hematol. 2012, 83 (2): 225-234. 10.1016/j.critrevonc.2011.11.001.
Article
PubMed
Google Scholar
Bastian PJ, Carter BH, Bjartell A, Seitz M, Stanislaus P, Montorsi F, Stief CG, Schroder F: Insignificant prostate cancer and active surveillance: from definition to clinical implications. Eur Urol. 2009, 55 (6): 1321-1330. 10.1016/j.eururo.2009.02.028.
Article
PubMed
Google Scholar
Klotz L: Active surveillance for prostate cancer: for whom?. J Clin Oncol. 2005, 23 (32): 8165-8169. 10.1200/JCO.2005.03.3134.
Article
PubMed
Google Scholar
Schostak M, Wiegel T, Muller M, Hoecht S, Schrader M, Straub B, Bottke D, Hinkelbein W, Miller K: Shared decision-making–results from an interdisciplinary consulting service for prostate cancer. World J Urol. 2004, 22 (6): 441-448. 10.1007/s00345-004-0447-3.
Article
CAS
PubMed
Google Scholar
DGU: Interdisciplinary S3-guidelines on the early detection, diagnostics and therapy of the different stages of prostate cancer; AWMF registration number (034-022OL), Version 2.0. 2011, Düsseldorf, Germany: Deutsche Gesellschaft für Urologie e. V. (German Urological Association)
Google Scholar
Tunn UW: Advanced prostate cancer treatment guidelines: European perspective. BJU Int. 2004, 94 (Suppl 3): 6-
Article
PubMed
Google Scholar
Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N, Schmid HP, van der Kwast T, Wiegel T: [EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease]. Actas Urol Esp. 2011, 35 (9): 501-514.
CAS
PubMed
Google Scholar
Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J: Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol. 2007, 177 (2): 540-545. 10.1016/j.juro.2006.10.097.
Article
CAS
PubMed
Google Scholar
Lobb EA, Gaff CL, Meiser B, Butow PN, Osseiran-Moisson R, Hallowell N: Attendance of men at the familial cancer clinic: what they value from the consultation. Genet Med. 2009, 11 (6): 434-440. 10.1097/GIM.0b013e3181a18982.
Article
PubMed
Google Scholar
Gattellari M, Butow PN, Tattersall MH: Sharing decisions in cancer care. Soc Sci Med. 2001, 52 (12): 1865-1878. 10.1016/S0277-9536(00)00303-8.
Article
CAS
PubMed
Google Scholar
Daskivich TJ, Chamie K, Kwan L, Labo J, Dash A, Greenfield S, Litwin MS: Improved prediction of long-term, other cause mortality in men with prostate cancer. J Urol. 2011, 186 (5): 1868-1873. 10.1016/j.juro.2011.07.033.
Article
PubMed
Google Scholar
Epstein JI, Allsbrook WC, Amin MB, Egevad LL: The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005, 29 (9): 1228-1242. 10.1097/01.pas.0000173646.99337.b1.
Article
PubMed
Google Scholar
Kunz I, Musch M, Roggenbuck U, Klevecka V, Kroepfl D: Tumour characteristics, oncological and functional outcomes in patients aged ≥ 70 years undergoing radical prostatectomy. BJU Int. 2013 Mar, 111 (3 Pt B): E24-E29. 10.1111/j.1464-410X.2012.11368.x. Epub 2012 Sep 5. PMID: 22947135
Article
PubMed
Google Scholar
Thaxton CS, Loeb S, Roehl KA, Kan D, Catalona WJ: Treatment outcomes of radical prostatectomy in potential candidates for 3 published active surveillance protocols. Urol. 2010, 75 (2): 414-418. 10.1016/j.urology.2009.07.1353.
Article
PubMed
Google Scholar
Feldman-Stewart D, Brundage MD, Van Manen L, Svenson O: Patient-focussed decision-making in early-stage prostate cancer: insights from a cognitively based decision aid. Health Expect. 2004, 7 (2): 126-141. 10.1111/j.1369-7625.2004.00271.x.
Article
PubMed
Google Scholar
Meghani SH, Lee CS, Hanlon AL, Bruner DW: Latent class cluster analysis to understand heterogeneity in prostate cancer treatment utilities. BMC Med Inform Decis Mak. 2009, 9: 47-10.1186/1472-6947-9-47.
Article
PubMed
PubMed Central
Google Scholar
Jenkins V, Fallowfield L, Saul J: Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer. 2001, 84 (1): 48-51. 10.1054/bjoc.2000.1573.
Article
CAS
PubMed
PubMed Central
Google Scholar
Feldman-Stewart D, Brundage MD, Nickel JC, MacKillop WJ: The information required by patients with early-stage prostate cancer in choosing their treatment. BJU Int. 2001, 87 (3): 218-223. 10.1046/j.1464-410x.2001.02046.x.
Article
CAS
PubMed
Google Scholar
Feldman-Stewart D, Brundage MD, Tong C: Information that affects patients' treatment choices for early stage prostate cancer: a review. Can J Urol. 2011, 18 (6): 5998-6006.
PubMed
Google Scholar
Davison BJ, Parker PA, Goldenberg SL: Patients' preferences for communicating a prostate cancer diagnosis and participating in medical decision-making. BJU Int. 2004, 93 (1): 47-51. 10.1111/j.1464-410X.2004.04553.x.
Article
CAS
PubMed
Google Scholar
Baade PD, Steginga SK, Pinnock CB, Aitken JF: Communicating prostate cancer risk: what should we be telling our patients?. Med J Aust. 2005, 182 (9): 472-475.
PubMed
Google Scholar
Resnick MJ, Guzzo TJ, Cowan JE, Knight SJ, Carroll PR, Penson DF: Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). BJU Int. 2013 Feb, 111 (2): 213-220. 10.1111/j.1464-410X.2012.11423.x. Epub 2012 Aug 29. PMID: 22928860
Article
PubMed
Google Scholar
Zeliadt SB, Ramsey SD, Penson DF, Hall IJ, Ekwueme DU, Stroud L, Lee JW: Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer. 2006, 106 (9): 1865-1874. 10.1002/cncr.21822.
Article
PubMed
Google Scholar
Snow SL, Panton RL, Butler LJ, Wilke DR, Rutledge RD, Bell DG, Rendon RA: Incomplete and inconsistent information provided to men making decisions for treatment of early-stage prostate cancer. Urol. 2007, 69 (5): 941-945. 10.1016/j.urology.2007.01.027.
Article
PubMed
Google Scholar
Goh AC, Kowalkowski MA, Bailey DE, Kazer MW, Knight SJ, Latini DM: Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance. BJU Int. 2012, 110 (2 Pt 2): E50-E56.
Article
PubMed
Google Scholar
Cohen H, Britten N: Who decides about prostate cancer treatment? A qualitative study. Fam Pract. 2003, 20 (6): 724-729. 10.1093/fampra/cmg617.
Article
PubMed
Google Scholar
Steginga SK, Occhipinti S, Gardiner RA, Yaxley J, Heathcote P: Making decisions about treatment for localized prostate cancer. BJU Int. 2002, 89 (3): 255-260. 10.1046/j.1464-4096.2001.01741.x.
Article
CAS
PubMed
Google Scholar
Sidana A, Hernandez DJ, Feng Z, Partin AW, Trock BJ, Saha S, Epstein JI: Treatment decision-making for localized prostate cancer: what younger men choose and why. Prostate. 2012, 72 (1): 58-64. 10.1002/pros.21406.
Article
PubMed
Google Scholar
Denberg TD, Melhado TV, Steiner JF: Patient treatment preferences in localized prostate carcinoma: the influence of emotion, misconception, and anecdote. Cancer. 2006, 107 (3): 620-630. 10.1002/cncr.22033.
Article
PubMed
Google Scholar
Linder SK, Swank PR, Vernon SW, Morgan RO, Mullen PD, Volk RJ: Is a prostate cancer screening anxiety measure invariant across two different samples of age-appropriate men?. BMC Med Inform Decis Mak. 2012, 12: 52-10.1186/1472-6947-12-52.
Article
PubMed
PubMed Central
Google Scholar
Efficace F, Bottomley A, van Andel G: Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials. Cancer. 2003, 97 (2): 377-388. 10.1002/cncr.11065.
Article
PubMed
Google Scholar
van Andel G, Bottomley A, Fossa SD, Efficace F, Coens C, Guerif S, Kynaston H, Gontero P, Thalmann G, Akdas A: An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer. 2008, 44 (16): 2418-2424. 10.1016/j.ejca.2008.07.030.
Article
PubMed
Google Scholar
Stockle M, Bussar-Maatz R: [Localised prostate cancer: the PREFERE trial]. Z Evid Fortbild Qual Gesundhwes. 2012, 106 (5): 333-335. 10.1016/j.zefq.2012.05.004. discussion 335
Article
PubMed
Google Scholar
Hambrock T, Hoeks C, Hulsbergen-Van De Kaa C, Scheenen T, Futterer J, Bouwense S, Van Oort I, Schroder F, Huisman H, Barentsz J: Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol. 2012, 61 (1): 177-184. 10.1016/j.eururo.2011.08.042.
Article
PubMed
Google Scholar
Danila DC, Fleisher M, Scher HI: Circulating tumor cells as biomarkers in prostate cancer. Clin Cancer Res. 2011, 17 (12): 3903-3912. 10.1158/1078-0432.CCR-10-2650.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lin HC, Wu HC, Chang CH, Li TC, Liang WM, Wang JY: Development of a real-time clinical decision support system upon the Web MVC-based architecture for prostate cancer treatment. BMC Med Inform Decis Mak. 2011, 11: 16-10.1186/1472-6947-11-16.
Article
CAS
PubMed
PubMed Central
Google Scholar
Diefenbach MA, Mohamed NE, Butz BP, Bar-Chama N, Stock R, Cesaretti J, Hassan W, Samadi D, Hall SJ: Acceptability and preliminary feasibility of an internet/CD-ROM-based education and decision program for early-stage prostate cancer patients: randomized pilot study. J Med Internet Res. 2012, 14 (1): e6-10.2196/jmir.1891.
Article
PubMed
PubMed Central
Google Scholar
Dorfman CS, Williams RM, Kassan EC, Red SN, Dawson DL, Tuong W, Parker ER, Ohene-Frempong J, Davis KM, Krist AH: The development of a web- and a print-based decision aid for prostate cancer screening. BMC Med Inform Decis Mak. 2010, 10: 12-10.1186/1472-6947-10-12.
Article
PubMed
PubMed Central
Google Scholar
Sheridan SL, Golin C, Bunton A, Lykes JB, Schwartz B, McCormack L, Driscoll D, Bangdiwala SI, Harris RP: Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials. BMC Med Inform Decis Mak. 2012, 12: 130-10.1186/1472-6947-12-130.
Article
PubMed
PubMed Central
Google Scholar
Dear RF, Barratt AL, Askie LM, Butow PN, McGeechan K, Crossing S, Currow DC, Tattersall MH: Impact of a cancer clinical trials web site on discussions about trial participation: a cluster randomized trial. Ann Oncol. 2012, 23 (7): 1912-1918. 10.1093/annonc/mdr585.
Article
CAS
PubMed
Google Scholar